About: ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2001

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2001 (uk) مقالة علمية تنشرت ف 1 دجنبر 2001 (ary) article scientifique publié en 2001 (fr) im Dezember 2001 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2001 (ast) scientific article published on 01 December 2001 (en)
publication date	wds:Q77336320-6DA7557B-3474-486F-9AD6-E50F330119B1
publication date	2001-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q77336320-6A7505BA-1923-47BD-A46B-31142B215B30
language of work or name	English
cites work	wds:Q77336320-00BCC978-50BD-4502-9B78-B2046C3FD4BA wds:Q77336320-018921A5-EA8A-4C0B-B796-A8D2D3FE5C6B wds:Q77336320-058D1F18-5A97-4318-A132-8504ED831F9C wds:Q77336320-06BBAC10-3C44-4CBE-9475-7A97F8DF6E7D wds:Q77336320-0D5D21CC-109B-4BBD-8F74-C5EFA81B7330 wds:Q77336320-11BDD72A-F69B-44BE-82AB-32AC43BA5A29 wds:Q77336320-15082478-6887-4CD4-8D15-F0DE3A47A378 wds:Q77336320-15454D53-08DE-4530-877C-F28C11B5EFBD wds:Q77336320-17B1147F-17DB-437D-A461-5306DB4E5054 wds:Q77336320-2B09CB8B-857A-4FE1-BD3E-9CB96DD8E6FA wds:Q77336320-34AF5CD8-B281-4A8E-ABC8-0C7B631E5C93 wds:Q77336320-3A1B235F-DBCC-44D3-9672-40D432AE9CFF wds:Q77336320-3B0CE8D7-CB89-4298-A08F-954882AB4AB2 wds:Q77336320-5031E98D-2667-4C3C-94C6-0A823ED5EE5B wds:Q77336320-5247976D-27BE-4AFB-B17B-00B792836034 wds:Q77336320-540CE45A-D11E-470B-A513-D5BD78149FEC wds:Q77336320-61AB1F2E-2EA5-4374-8207-8B28119E876A wds:Q77336320-626FD661-CB63-4C8F-9490-C6401AEC9D16 wds:Q77336320-71EC9CBB-7383-4074-96AB-AD988294B6CD wds:Q77336320-7320FED4-8D35-4D37-A3D5-6297D053693D wds:Q77336320-7786C639-5BC4-4502-82F6-05A3F26E059F wds:Q77336320-78824252-82BE-4002-BA89-C8102956B0E4 wds:Q77336320-7B0712F1-AC19-4ADD-A63E-867D36EA9F10 wds:Q77336320-90B10F9E-3C15-40F6-8BEC-252FBCFC2374 wds:Q77336320-9EB7C546-4291-4CC3-81F5-2539FC746D10 wds:Q77336320-9F67BFB4-06BC-40C0-AA63-71FD70F86F6B wds:Q77336320-A0878D3F-8B05-4B65-8178-09AA642617FE wds:Q77336320-A53185AD-E5FA-4D59-BDED-C10F35C8A547 wds:Q77336320-ABF09DF2-92AA-4939-9A92-1A448DB23B10 wds:Q77336320-B7E1F0EC-3D23-4125-B35E-8FD3C8CD05F4 wds:Q77336320-BBFB3DD2-BC8B-4C2B-8EA6-754AF219ECE4 wds:Q77336320-BEC76F96-DC3B-4A3C-9251-7A3A583499E6 wds:Q77336320-C18B8945-6A6F-40DB-9EE4-68492AF380B6 wds:Q77336320-C500A133-CD33-40E1-843F-656A6B1D00CD wds:Q77336320-C632A004-786D-4153-B59E-3B34C416FDD9 wds:Q77336320-D49FAF95-48A3-46F3-9238-5F20906C627A wds:Q77336320-E8844624-9B3A-49FD-9265-BD88C6E38EC0 wds:Q77336320-EC6919E9-5F42-4444-A279-F2DDE267144E wds:Q77336320-ECB12B75-A0E1-43D7-851A-064333F79806 wds:Q77336320-EDE9BAB0-0CF4-4A1F-9BBB-3B33ED099297 wds:Q77336320-F306D66E-3469-43DC-92E1-03FD8B0B6912
cites work	Effect of chitosan on epithelial permeability and structure. Chitosan as a novel nasal delivery system for peptide drugs Screening of cationic compounds as an absorption enhancer for nasal drug delivery A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Chitosan: a unique polysaccharide for drug delivery. Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2) Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract The common mucosal immune system and current strategies for induction of immune responses in external secretions Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407. Mucosal immunity and tolerance: relevance to vaccine development Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice Chitin biotechnology applications Immunostimulatory DNA is a potent mucosal adjuvant Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Mucosal immunity: implications for vaccine development Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants Poloxamer 407-induced atherogenesis in the C57BL/6 mouse Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. Immunological activity of chitin and its derivatives. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice The nasal mucociliary clearance: relevance to nasal drug delivery In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery Drug metabolism in the nasal mucosa Percutaneous absorption of indomethacin from pluronic F127 gels in rats Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses Adjuvant activity of chitin derivatives in mice and guinea-pigs. Intranasal immunization of mice against influenza with synthetic peptides anchored to proteosomes Evaluation of pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant Surface active agents as enhancers of alveolar absorption
author name string	wds:Q77336320-0F6D0A39-DA4D-422C-928D-61D67E4D700F wds:Q77336320-164566E2-2179-4269-A682-CC77CD97A1B8 wds:Q77336320-3ABFEEF4-E91A-4092-ADFB-5C574721C6C5 wds:Q77336320-666F9FF5-D70C-4F92-A433-75034A93B6CC wds:Q77336320-D1E6C229-0979-43EC-99D9-F68DF379A13C wds:Q77336320-EEAD0AC3-D2BA-4E33-A488-C0847D670BDB

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software